Treatment of lipoid proteinosis due to the p.C220G mutation in ECM1, a major allele in Chinese patients

被引:0
|
作者
Rong Zhang
Yang Liu
Yang Xue
Yinan Wang
Xinwen Wang
Songtao Shi
Tao Cai
Qintao Wang
机构
[1] Department of Periodontology,State Key Laboratory of Military Stomatology
[2] School of Stomatology,Department of Stomatology
[3] the Fourth Military Medical University,State Key Laboratory of Military Stomatology
[4] The 309th Hospital of Chinese People’s Liberation Army,Department of Plastic and Burns Surgery
[5] Department of Oral Biology,Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry
[6] School of Stomatology,Oral Medicine Research Institute
[7] the Fourth Military Medical University,undefined
[8] Tangdu Hospital,undefined
[9] the Fourth Military Medical University,undefined
[10] University of Southern California,undefined
[11] School of Stomatology,undefined
[12] the Fourth Military Medical University,undefined
关键词
Extracellular matrix protein 1; Lipoid proteinosis; Anaphylaxis; Glucocorticoid; Anaphylaxis; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Identification and clinical characterization of Charcot-Marie-Tooth disease type 1C patients with LITAF p.G112S mutation
    Park, Jaehong
    Kim, Hyun Su
    Kwon, Hye Mi
    Kim, Jiah
    Nam, Soo Hyun
    Jung, Na Young
    Lee, Ah Jin
    Jung, Young Hee
    Kim, Sang Beom
    Chung, Ki Wha
    Choi, Byung-Ok
    GENES & GENOMICS, 2022, 44 (8) : 1007 - 1016
  • [42] Rapid-Onset Dystonia-Parkinsonism in a Chinese Girl with a De Novo ATP1A3 c.2267G>A (p.R756H) Genetic Mutation
    Tan, Ai Huey
    Ozelius, Laurie J.
    Brashear, Allison
    Lang, Anthony E.
    Ahmad-Annuar, Azlina
    Tan, Chong Tin
    Lim, Shen-Yang
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2015, 2 (01): : 74 - 75
  • [43] KRAS p.G12C mutation occurs in 1% of EGFR-mutated advanced non-small-cell lung cancer patients progressing on a first-line treatment with a tyrosine kinase inhibitor
    Serna-Blasco, R.
    Sanchez-Herrero, E.
    Sanz-Moreno, S.
    Rodriguez-Festa, A.
    Garcia-Veros, E.
    Casarrubios, M.
    Sierra-Rodero, B.
    Laza-Briviesca, R.
    Cruz-Bermudez, A.
    Mielgo-Rubio, X.
    Sanchez-Hernandez, A.
    Uribelarrea, E. A.
    Romero, V. Calvo A.
    Provencio, M.
    ESMO OPEN, 2021, 6 (05)
  • [44] The Genetic Homogeneity of CAMS Syndrome: Four New Patients With the c.2452G>A (p.Glu818Lys) Mutation in the ATP1A3 Gene
    Maas, Roderick P. P. W. M.
    Schieving, Jolanda H.
    Schouten, Meyke
    Kamsteeg, Erik-Jan
    van de Warrenburg, Bart P. C.
    PEDIATRIC NEUROLOGY, 2016, 59 : 71 - 75
  • [45] Autosomal Dominant Growth Hormone Deficiency due to a Novel c.178G>A Mutation in the GH1 Gene Causing Instability of the Mutant GH Protein (p.Ala34Thr)
    Miller, Bradley
    Tan, Jimmy
    Parween, Shaheena
    Eble, Andree
    Ternand, Christine
    Gregory, Louise
    Dattani, Mehul
    Pandey, Amit
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 380 - 380
  • [46] Updated Phase 1 results from the PYNNACLE Phase 1/2 study of PC14586, a selective p53 reactivator, in patients with advanced solid tumors harboring a TP53 Y220C mutation
    Andronikou, Christina
    Burdova, Kamila
    Dibitetto, Diego
    Lieftink, Cor
    Beijersbergen, Roderick L.
    Hanzlikova, Hana
    Jonkers, Jos
    Rottenberg, Sven
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [47] Trial in Progress: A Phase 1b Study of Sotorasib, a KRAS (G12C) Inhibitor, in Combination with other Anticancer Therapies in Patients with Advanced Solid Tumors Harboring KRAS p.G12C Mutation (CodeBreaK101)
    Fakih, M.
    Durm, G.
    Govindan, R.
    Falchook, G.
    Soman, N.
    Henary, H.
    Hong, D. S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S28 - S28
  • [48] A novel missense COL10A1 mutation: c.2020G > A; p. Gly674Arg linked with the bowed legs stature in the Schmid metaphyseal chondrodysplasia-affected Chinese lineage
    Chen, Qiong
    Wu, Sheng-Nan
    Chen, Yong-Xing
    Kumar, Selvaa C.
    Zhang, Lu
    Wei, Hai-Yan
    Kumar, Senthil Arun
    BONE REPORTS, 2020, 12
  • [49] LONG-TERM OUTCOMES FOLLOWING COMBINATION TREATMENT WITH BOCEPREVIR PLUS PEG-INTRON/RIBAVIRIN (P/R) IN PATIENTS WITH CHRONIC HEPATITIS C, GENOTYPE 1 (CHC-G1)
    Vierling, J. M.
    Ralston, R.
    Lawitz, E. J.
    McCone, J.
    Gordon, S.
    Pound, D.
    Davis, M.
    Galati, J.
    Jacobson, I.
    Rossaro, L.
    Anderson, F. H.
    King, J.
    Cassidy, W.
    Bourliere, M.
    Esteban-Mur, R.
    Ravendhran, N.
    Galler, G.
    Mendez, P.
    Brass, C. A.
    Albrecht, J. K.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S470 - S471
  • [50] COINHERITANCE OF A NOVEL MUTATION ON THE HBA1 GENE: c.187delG (p.W62fsX66) [codon 62 (-G) (α1)] WITH THE α212 PATCHWORK ALLELE AND Hb S [β6(A3)Glu→Val, GAG>GTG; HBB: c.20A>T]
    Scheps, Karen G.
    De Paula, Silvia M.
    Bitsman, Alicia R.
    Freigeiro, Daniel H.
    Nora Basack, F.
    Pennesi, Sandra P.
    Varela, Viviana
    HEMOGLOBIN, 2013, 37 (05) : 492 - 500